Risk of clots, stroke from incorrect blood thinner dosing reduced using online dashboard

Direct oral anticoagulants are the most popular blood thinners, yet doctors commonly prescribe the wrong dose

12:17 PM

Author | Noah Fromson

prescription pad blue yellow sketch
Jacob Dwyer, Justine Ross, Michigan Medicine

Doctors and pharmacists treating people with blood thinners can reduce the rate of inappropriate dosing — as well as blood clots and strokes that can result from it — using an electronic patient management system, a study suggests.

The online dashboard, developed by the United States Veterans Health Administration in 2016, was designed to highlight and optimize the treatment of patients with direct oral anticoagulants, or DOACs, the most commonly prescribed blood thinners. 

Researchers led by Michigan Medicine used the tool to assess over 120,000 cases in which patients with atrial fibrillation or venous thromboembolism, blood clots in the veins, were treated with DOACs at 123 VA hospitals from mid-2015 through 2019. 

SEE ALSO: Popular blood thinner associated with higher risk of bleeding complications

They found that between 6.9 and 8.6% of patients received incorrect prescriptions for blood thinners. 

Adoption of the electronic DOAC patient management tool led to a decline in off-label dosing of around 8%.

The rate of blood clots and stroke also declined at every hospital that implemented the monitoring tool.

Results are published in the Journal of the American Heart Association

“While DOACs are lifesaving medications for patients with common thrombotic conditions, they can also cause serious harm when prescribed inappropriately,” said Geoffrey Barnes, M.D., M.Sc., first author and associate professor of cardiology-internal medicine at U-M Medical School.

“Not only does our study show how commonly off-label dosing of DOACs occurs, but it highlights that utilizing this DOAC population health management tool can reduce that rate of inappropriate dosing as well as downstream complications, such as stroke and clotting.”

Direct oral anticoagulants can be incorrectly prescribed up to 20% of the time. 

The two most prescribed DOACs are rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis.)

SEE ALSO: Most blood thinner dosing problems happen after initial prescription

The sites that used the system the longest demonstrated a more significant decline in inappropriate prescribing. 

In Michigan, the Michigan Anticoagulation Quality Improvement Initiative, a multi-center collaborative of statewide hospitals, built a similar dashboard using the Epic™ electronic health record. 

Five hospitals across the state currently use that system, including University of Michigan Health. 

“This study provides one of the largest and most impactful evaluations of an anticoagulation stewardship effort to show reduction in adverse clinical events,” Barnes said.

“Health systems and policymakers should consider investing in anticoagulation stewardship efforts that support pharmacists in reviewing and correcting off label direct oral anticoagulant dosing for the benefit of millions of patients who take these medications.”

Additional authors: Joshua Errickson, Ph.D., F. Jacob Seagull, Ph.D., Michael P. Dorsch, PharmD, M.S., Jeremy B. Sussman, M.D., M.S., all of University of Michigan, Charity Chen, M.S., and Rob Holleman, M.P.H., Sussman, all of the Ann Arbor VA Center for Clinical Management Research, Arthur L Allen, PharmD, CACP, of Veterans Affairs Salt Lake City Health Care System, and Patrick Spoutz, PharmD, BCPS, of Veterans Integrates Service Network 20. 

Funding/disclosures: This project was funded by the Agency for Healthcare Research and Quality (AHRQ) through grant R18HS026874.

Support for MAQI2 is provided by Blue Cross Blue Shield of Michigan and Blue Care Network as part of the BCBSM Value Partnerships program.

Although Blue Cross Blue Shield of Michigan and MAQI2 work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.

Barnes consults for Pfizer, Bristol-Myers Squibb, Janssen, Bayer and AstraZeneca. He is on the Board of Directors for the Anticoagulation Forum. 

Paper cited: “Pharmacist Use of a Population Management Dashboard for Safe Anticoagulant Prescribing: Evaluation of a Nation-wide Implementation Effort,” Journal of the American Heart AssociationDOI: 10.1161/JAHA.124.035859

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week by subscribing to Health Lab’s two newsletters, Health & Wellness and Research & Innovation.

Sign up for the Health Lab Podcast: Add us on SpotifyApple Podcasts or wherever you get you listen to your favorite shows.


More Articles About: Cardiovascular: Diseases & Conditions Coagulation Disorders Atrial fibrillation (Afib) Deep Vein Thrombosis (DVT) Heart disease Arrhythmia or Abnormal Heart Rhythms Cardiovascular: Preventive Cardiology Cardiac Medications Medication Interactions Pharmacy Emerging Technologies Health Care Delivery, Policy and Economics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story
Geoff Barnes headshot Geoffrey D Barnes, MD, MSc

Associate Professor

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories girl hugging teddy bear with alcohol bottles on ground
Health Lab
1 in 4 kids live with parents who have alcohol or other drug problems
Children living with parents who have addiction issues, also called substance used disorder, have higher risks later in life. A new study shows 1 in 4 currently live in such households.
2025 blocks with stethoscope
Health Lab
Top 10 things to know about your health costs right now
From Medicare prescription costs and medical debt rules to actions that the Supreme Court, Congress and President Trump have taken or could take, a guide to health policies that affect many people.
american flag with stethoscope on it
Health Lab
What does Medicaid do?
Medicaid provides health insurance coverage for tens of millions of American children and adults. Research on its impact shows positive effects in many ways.
red cells stacked ontop of darker red background
Health Lab
Medicaid unwinding linked to opioid addiction treatment disruptions
Buprenorphine prescription interruptions were most common in states that had the biggest coverage drops during Medicaid unwinding; study has importance for future Medicaid policy.
woman looking at orange empty pill bottles with daughter on couch
Health Lab
Medicaid unwinding disrupted young people’s access to chronic disease medicines
Children and young adults living in the states with the highest Medicaid enrollment drops during the “unwinding” process were more likely to have disruptions in mental health, asthma and epilepsy medication.
up close doctor in hospital with cardiology close up scans on monitors
Health Lab
Researchers find significant differences in care of life threatening shock after heart attack
A study finds most hospitals don’t see many cardiogenic shock patients. When they do, providers often do not have a standardized way of treating them.